Henry Schein, Inc. announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. This transaction solidifies KKR's position as the holder of approximately 12% of Henry Schein's common shares.
In connection with the investment, William K. “Dan” Daniel, Executive Advisor to KKR, officially joined Henry Schein’s Board of Directors as an independent director. Max Lin, Partner at KKR, had previously become a member of the Board on May 2, 2025.
These appointments integrate KKR's deep experience in healthcare, operations, and strategic growth into Henry Schein's governance. Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair, and Mr. Daniel was appointed to the Compensation Committee, with both joining the Strategic Advisory Committee.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.